These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 28448701)

  • 1. Valproate Intoxication in a Patient With Blood Valproate Levels Within Therapeutic Range.
    Smits JEMP; Wallenburg E; van Spanje A; van Luin M; Marijnissen RM
    J Clin Psychiatry; 2017 Apr; 78(4):e413-e414. PubMed ID: 28448701
    [No Abstract]   [Full Text] [Related]  

  • 2. Toxic interaction between valproate and oxcarbazepine: a case detected by the free valproate level.
    Xiong GL; Ferranti J; Leamon MH
    J Clin Psychopharmacol; 2008 Aug; 28(4):472-3. PubMed ID: 18626286
    [No Abstract]   [Full Text] [Related]  

  • 3. Dose-dependent valproate-induced alopecia in patients with mental disorders.
    Tomita T; Goto H; Yoshida T; Tanaka K; Sumiya K; Kohda Y
    Indian J Pharmacol; 2015; 47(6):690-2. PubMed ID: 26729968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The valproate serum level in maintenance therapy for bipolar disorder in Japan.
    Machino A; Jitsuiki H; Okamoto Y; Izumitani S; Kimura Y; Suzuki K; Tanaka T; Inoue T; Koyama T; Wada K; Masaoka Y; Sasaki T; Yoshimura R; Nakamura J; Sumitan S; Ohmori T; Yamawaki S
    Hiroshima J Med Sci; 2013 Mar; 62(1):7-12. PubMed ID: 23600328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Divalproex in the treatment of bipolar disorder.
    Keck PE; McElroy SL
    Psychopharmacol Bull; 2003; 37 Suppl 2():67-73. PubMed ID: 15021862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does valproic acid warrant therapeutic drug monitoring in bipolar affective disorder?
    Haymond J; Ensom MH
    Ther Drug Monit; 2010 Feb; 32(1):19-29. PubMed ID: 19901867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical correlates of response to valproate in geriatric inpatients.
    Niedermier JA; Nasrallah HA
    Ann Clin Psychiatry; 1998 Dec; 10(4):165-8. PubMed ID: 9988057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Letter to the editor-Reflections on "Total valproate versus free valproate in therapeutic drug monitoring for bipolar disorder: A cross-sectional study".
    Wei LC; Tan HK
    Asia Pac Psychiatry; 2024 Jun; 16(2):e12562. PubMed ID: 38887176
    [No Abstract]   [Full Text] [Related]  

  • 9. Serum Valproic Acid Levels During Initial Conversion of Antituberculoid Therapy in Bipolar Mania: A Case Report and Literature Review.
    DeLucia B; Mahon J
    Psychosomatics; 2017; 58(4):446-449. PubMed ID: 28413090
    [No Abstract]   [Full Text] [Related]  

  • 10. Valproate in bipolar disorder: 2000 onwards.
    Bowden CL; Singh V
    Acta Psychiatr Scand Suppl; 2005; (426):13-20. PubMed ID: 15833096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Teaching neuroimages: reversible paradoxical lithium neurotoxicity.
    Vishnu VY; Kesav P; Goyal MK; Modi M; Prabhakar S
    Neurology; 2013 Oct; 81(14):e110. PubMed ID: 24081968
    [No Abstract]   [Full Text] [Related]  

  • 12. [Valproate induced hypoactive delirium in a bipolar disorder patient with psychotic features].
    Ozen S; Bülbül I; Soyuçok E
    Turk Psikiyatri Derg; 2010; 21(1):79-84. PubMed ID: 20204907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Linear relationship of valproate serum concentration to response and optimal serum levels for acute mania.
    Allen MH; Hirschfeld RM; Wozniak PJ; Baker JD; Bowden CL
    Am J Psychiatry; 2006 Feb; 163(2):272-5. PubMed ID: 16449481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A 12-week, open, randomized trial comparing sodium valproate to lithium in patients with bipolar I disorder suffering from a manic episode.
    Bowden C; Göğüş A; Grunze H; Häggström L; Rybakowski J; Vieta E
    Int Clin Psychopharmacol; 2008 Sep; 23(5):254-62. PubMed ID: 18703934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of valproate plasma concentrations and dose in bipolar affective disorder.
    Perry PJ; Bever-Stille KA; Arndt S; Gundersen S
    J Clin Psychopharmacol; 2000 Apr; 20(2):277-9. PubMed ID: 10770477
    [No Abstract]   [Full Text] [Related]  

  • 16. Appropriateness of plasma level determinations for lithium and valproate in routine care of psychiatric inpatients with affective disorders.
    Mann K; Hiemke C; Lotz J; Schmidt LG; Lackner KJ; Bates DW
    J Clin Psychopharmacol; 2006 Dec; 26(6):671-3. PubMed ID: 17110832
    [No Abstract]   [Full Text] [Related]  

  • 17. Population Pharmacokinetics of Valproic Acid in Patients with Mania: Implication for Individualized Dosing Regimens.
    Methaneethorn J
    Clin Ther; 2017 Jun; 39(6):1171-1181. PubMed ID: 28483293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lamotrigine add-on to valproate therapy for paediatric bipolar affective disorder.
    Thakur A; Jagadheesan K; Sinha VK
    Aust N Z J Psychiatry; 2005 Jul; 39(7):639. PubMed ID: 15996148
    [No Abstract]   [Full Text] [Related]  

  • 19. Intravenous valproate treatment: some observations.
    Duggal HS
    Can J Psychiatry; 2002 Feb; 47(1):96. PubMed ID: 11873717
    [No Abstract]   [Full Text] [Related]  

  • 20. NICE recommendations for valproate treatment are unhelpful.
    Curtis D; Kerr M
    Br J Psychiatry; 2005 May; 186():447. PubMed ID: 15863754
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.